Endometrial cancer
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patient was diagnosed with endometrial cancer, and the preoperative imaging examination suggested that the diagnosis was stage I (FIGO 2009 stage); 2. The pathology of curettage was endometrioid carcinoma; 3. Pathology suggests high or moderate differentiation (G1 or G2); 4. Age 18-80 years old (inclusive); 5. Be able to cooperate with and complete follow-up and related examinations; 6. Voluntarily participate in the experiment and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. There is a serious uncontrolled disease or acute infection; 2. Patients with cardiovascular and cerebrovascular diseases, blood system diseases, immune system diseases and diabetes that cannot be controlled and cannot meet the surgical standards; 3. Scrape pathology suggested low differentiation or high grade (G3); 4. The pathology of curettage indicated serous carcinoma, clear cell carcinoma and carcinosarcoma; 5. Preoperative radiotherapy, chemotherapy and other adjuvant treatment; 6. Imaging showed positive pelvic or abdominal paraaortic lymph nodes; 7. Poor vaginal conditions, unable to complete removal of the uterus (assessed by researchers); 8. Patients with serious pelvic and abdominal adhesions who are not suitable for laparoscopic surgery; 9. Participants in other investigational drug or device clinical trials have not been completed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of unconverted surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Operation time;Sentinel lymph node resection;Intraoperative bleeding;Intraoperative blood transfusion;Sentinel lymph node imaging success ratio;Location and number of sentinel lymph nodes removed;Postoperative pain score;Incidence of device defects;Surgeon's satisfaction; | — |
Countries
China
Contacts
Peking Union Hospital, Chinese Academy of Medical Sciences